e-NIOS
The AI engine Fit Assessment
Betae-NIOS leverages machine learning for genomic data analysis, enabling the discovery of new patterns and the development of novel therapeutics.
Blurb
e-NIOS delivers unsupervised interpretation of genomic data
HQ Location
Greece
Founded
2013
Employees
1 - 10
Total funding raised
$233.37K
Last Funding Event
Seed, $109.31K, January 10, 2016
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Genomic Data Analysis
- Biomarker Identification
Operator of genomic data analysis and interpretation platform designed to automate biomarker discovery for precision medicine. The company's platform offers an unsupervised analysis of complex genomic, and multi-omic data, and accelerates the discovery of critical biomarkers, and the technology incorporates biological knowledge into data mining, enabling researchers to deliver novel molecular markers or targets for diagnostics and therapeutics.